APA (7th ed.) Citation

Melchior, B., Mittapalli, G. K., Lai, C., Duong‐Polk, K., Stewart, J., Güner, B., . . . Yazici, Y. (2019). Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease. Aging Cell, 18(5), N.PAG. https://doi.org/10.1111/acel.13000

Chicago Style (17th ed.) Citation

Melchior, Benoît, et al. "Tau Pathology Reduction with SM07883, a Novel, Potent, and Selective Oral DYRK1A Inhibitor: A Potential Therapeutic for Alzheimer's Disease." Aging Cell 18, no. 5 (2019): N.PAG. https://doi.org/10.1111/acel.13000.

MLA (9th ed.) Citation

Melchior, Benoît, et al. "Tau Pathology Reduction with SM07883, a Novel, Potent, and Selective Oral DYRK1A Inhibitor: A Potential Therapeutic for Alzheimer's Disease." Aging Cell, vol. 18, no. 5, 2019, p. N.PAG, https://doi.org/10.1111/acel.13000.